This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra ...

Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, ...

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...

For decades, television advertising has been a game of creativity and repetition. Jingles and mascots became part of our ...

California’s top public health officials declared vaccines as “one of the greatest achievements in modern medicine” Friday in ...

What you won’t see, though, are green ones. The reason for this is both a fault in the stars and in ourselves: we don’t see ...

Giving final approval to a drug carries significant legal risks, essentially certifying that the medicine meets FDA standards ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

In the recent study on pain, researchers investigated three variations in the SCN9A gene, and reported greater pain ...